Join the FDA’s Office of Study Integrity and Surveillance (OSIS), on July 19-20, 2022, as they host the workshop, CDER Inspections of Good Laboratory Practice, Animal Rule, and Bioavailability/Bioequivalence Study Sites, intended for regulatory affairs professionals as well as researchers, sponsors, and other industry professionals involved in bioanalysis. The first day will include fours sessions including:
- Overview of Good Laboratory Practice (GLP) Regulations and Compliance Programs (CPs)
- Overview of OSIS BA/BE Program – Types of Studies
- Overview of Clinical BA/BE Inspections – Clinical Compliance Program
- Overview of Analytical BA/BE Inspections – Analytical Compliance Program
- It’s Not All about the Benjamins– Other Hurdles Presented by Research Participation, and Why Payment Won’t Resolve Them
The second day will focus on case studies exploring situations confronted by OSIS during inspection of sites, including topics like Clinical BA/BE, immunogenicity, and more.
Visit the workshop page for registration information, a complete agenda, additional information about each session, and available CIP credits.